GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Deferred Policy Acquisition Costs

Ascelia Pharma AB (OSTO:ACE) Deferred Policy Acquisition Costs


View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Ascelia Pharma AB (OSTO:ACE) Business Description

Industry
Traded in Other Exchanges
Address
Hyllie Boulevard 34, Malmo, SWE, SE-215 32
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.